… for drugs with potential to slow or stop Parkinson’s from getting worse,” said Gaia Skibinski, PhD, director of … cell functioning in ways that prevent alpha-synuclein from accumulating and becoming toxic.    TRPML1 , a protein … and, when activated, may clear alpha-synuclein clumps from cells before they endanger dopamine neurons.   OGA, a …

… therapies. This program was funded with a lead gift from the Edmond J. Safra Philanthropic Foundation in memory … including depression, apathy and fatigue. Positive results from this trial would provide physicians with an optimal exercise regimen to prescribe patients suffering from postural instability and gait disorders, something that …

… “ Multi-single Unit Elextrophsiological Characterization of Dyskinesia Induced by Dopaminetic Drug ” Kimberly Bjugstad, … Hospital “ Adenosine A2A Receptors in a Mouse Model of PD Dyskinesia ” Michael Sierks, PhD Arizona State University “ …

… We know from Alzheimer’s disease the difference an imaging tracer … ( previously funded by MJFF) thanks to a $20 million grant from the National Institute of Neurological Disorders and Stroke. We also announced three winners from the Ken Griffin Alpha-synuclein Imaging Competition …

… progressively complex nature of the practice and feedback from the clinician leads to consistent improvement. The LSVT program, developed in the early 1990’s, progresses from practice of single words to short phrases to functional … geography and insurance reimbursement can keep patients from enrolling in the demanding LSVT program. As it is the …

… on the latest news in Parkinson’s disease research, live from the Movement Disorder Society International Congress in … (PD). As Dr. Volpe resumed playing, he noticed the man rise from his seat in the bar, and he began to dance – … one year to this week in Dublin. That initial nugget culled from a bar in County Clare has turned into positive results …